Testosterone Pellets for Subcutaneous Implantation Shortage
Last Updated: December 10, 2020
- Endo Pharmaceuticals did not provide a reason for the shortage.
- Testopel pellet, Endo Pharmaceuticals, 75 mg, for subcutaneous implantation 10 count, NDC 66887-0004-10
- Testopel pellet, Endo Pharmaceuticals, 75 mg, for subcutaneous implantation 100 count, NDC 66887-0004-20
Estimated Resupply Dates
- Endo Pharmaceuticals has Testopel pellets for subcutaneous implantation available.
Updated December 10, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 13, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.